Modulation of alternative splicing induced by paclitaxel in human lung cancer

Paclitaxel is utilized as the first-line chemotherapeutic regimen for the majority of advanced non-small-cell lung carcinoma. However, whether paclitaxel could suppress cancer progression through modulating RNA alternative splicing remains largely unknown. Here, we demonstrated the effects of paclit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ziran, Chen, Dan, Zhang, Wenjing, Zhao, Jinyao, Zhi, Lili, Huang, Fang, Ji, Haoyu, Zhang, Jinrui, Liu, Han, Zou, Lijuan, Wang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924756/
https://www.ncbi.nlm.nih.gov/pubmed/29706628
http://dx.doi.org/10.1038/s41419-018-0539-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924756/
https://www.ncbi.nlm.nih.gov/pubmed/29706628
http://dx.doi.org/10.1038/s41419-018-0539-4

Ejemplares similares